Evidence-based guideline: Treatment of tardive syndromes
Report of the Guideline Development Subcommittee of the American Academy of Neurology
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:

Article Information
- Received October 5, 2012
- Accepted in final form April 22, 2013
- First Published July 29, 2013.
Author Disclosures
- Roongroj Bhidayasiri, MD, FRCP,
- Stanley Fahn, MD, FAAN,
- William J. Weiner, MD, FAAN†,
- Gary S. Gronseth, MD, FAAN,
- Kelly L. Sullivan, PhD and
- Theresa A. Zesiewicz, MD, FAAN
- Roongroj Bhidayasiri, MD, FRCP,
1) Scientific advisory board, Ministry of Public Health, Thailand 2) Ipsen pharmaceuticals
NONE
Abbott, BL Hua, Boehringer-Ingelheim, GlaxoSmithKline, Medtronic, Novartis, Roche pharmaceuticals
Thai Journal of Neurology: Editor-in-chief (2010-2012)
1) Laser cane for Parkinson disease 2) Electronic Parkinson Disease Diary software for PDA
1) Neurological differential diagnosis, Wiley-Blackwell, 2005 2) International Neurology, Wiley-Blackwell, 2009 3) Movement Disorders: A video atlas, Humana Press, 2012
1) Chulalongkorn University, Associate Professor of Neurology 2) UCLA School of Medicine, Visiting Associate Professor of Neurology
Ipsen pharmaceuticals
Abbott, BL Hua, Boehringer-Ingelheim, GlaxoSmithKline, Medtronic, Novartis, Roche pharmaceuticals
Director of Chulalongkorn Center of Excellence on Parkinson's Disease & Related Disorders, Thai Red Cross society
NONE
1) Duodopa, Abbott pharmaceuticals 2) HMS 90 Whey protein isolate, Immunocal Thailand
1) Thailand Research Fund: 2008-2009
1) Rachadaphiseksomphot Endowment Fund part of the “Strengthen CU's Researcher's Project, Chulalongkorn University, Bangkok, Thailand. 2) Research unit grant number GRU 52-026- 30-005 of Chulalongkorn University, Bangkok, Thailand.
1) Thai Red Cross society, Parkinson Disease Center Development Grant
NONE
NONE
NONE
NONE
NONE
NONE
- Stanley Fahn, MD, FAAN,
Commercial - Merz Pharma
NONE
Commercial - Sun Pharmaceuticals India for travel and honoraria to speak at a course for neurologists in India
Springer Publishers for serving as co-editor of Current Neurology and Neurosurgery Report
NONE
Elsevier Publishers for co-authorship of book "Principles and Practice of Movement Disorders"
Columbia University
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Parkinson's Disease Foundation Smart Family Foundation (Dec. 2012).
NONE
NONE
NONE
NONE
NONE
NONE
- William J. Weiner, MD, FAAN†,
Served on the scientific advisory boards for (1) Santhera; (2) Rexahn
NONE
NONE
(1) Current Treatment Options in Neurology - Editor; (2) Parkinsonism and Related Disorders - Editorial Board (3) Journal of Neurological Reviews
NONE
Royalties from Lippicott Williams Wilkins, Elsevier, Hopkins
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gary S. Gronseth, MD, FAAN,
NONE
NONE
NONE
Neurology Now
NONE
NONE
NONE
NONE
Boehringer Ingelheim 2007-2011(Resigned Dec 2011)
NONE
NONE
NONE
NONE
NONE
American Academy of Neurology
NONE
NONE
NONE
NONE
NONE
NONE
- Kelly L. Sullivan, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Theresa A. Zesiewicz, MD, FAAN
NONE
NONE
(1) TEVA- speaking engagements (2) UCB Speakers Bureau (3) GE Healthcare Speaker Program
Tremor and Other Hyperkinetic Movement Disorders, Editorial Board 2011
NONE
NONE
(1) TEVA- speaking engagements (2) UCB Speakers Bureau (3) GE Healthcare Speaker Program
NONE
(1) TEVA (2) UCB (3) GE Healthcare
NONE
NONE
(1) GlaxoSmithKline (2) UCB Pharmaceuticals (3) Edison Pharmaceuticals (4) Boehringer-Ingelheim (5) Novartis (6) Teva Neuroscience (7) Pfizer (8) Allergan.
(1) UCLA-RAND
NONE
(1) National Ataxia Foundation, grant support (2) Friedreich's Ataxia Research Association, grant support (3) Bobby Allison Ataxia Research Center, grant support
NONE
NONE
NONE
NONE
NONE
NONE
- From the Chulalongkorn Parkinson's Disease and Related Disorders Center of Excellence, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (R.B.), Bangkok, Thailand; Department of Neurology (R.B.), David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Neurology (S.F.), Columbia University, New York, NY; Department of Neurology (W.J.W.), University of Maryland, Baltimore, MD; Department of Neurology (G.S.G.), University of Kansas Medical Center, Kansas City, KS; and Department of Neurology (K.L.S., T.A.Z.), University of South Florida, Tampa, FL.
- Correspondence to American Academy of Neurology: guidelines{at}aan.com
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
- Reply from the guideline authors
- Roongroj Bhidayasiri, Director and Associate Professor of Neurology, Chulalongkorn University, Department of Medicine, Bangkok, Thailandguidelines@aan.com
- Stanley Fahn, New York, NY; Gary S. Gronseth, Kansas City, KS; Kelly L. Sullivan, Tampa, FL; Theresa A. Zesiewicz, Tampa, FL
Submitted September 04, 2013 - Evidence-based guideline: Treatment of tardive syndromes Report of the Guideline Development Subcommittee of the American Academy of Neurology
- Vladimir Lerner, Director of psychiatric ward, Ben Gurion University of the Negev, Be'er Sheva, Israellernervld@yahoo.com
- Chanoch Miodownik, Vladimir Lerner, Be'er Sheva, Israel
Submitted August 21, 2013
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.